Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 332 results in range #501 to #832.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Dose-length product‏‎ (2 revisions)
  2. Equieffective dose‏‎ (2 revisions)
  3. Expanded and aligned radiation field‏‎ (2 revisions)
  4. Qualified expert‏‎ (2 revisions)
  5. Adventitious‏‎ (2 revisions)
  6. Radioactive substance‏‎ (2 revisions)
  7. Habitual nose breather‏‎ (2 revisions)
  8. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  9. Background dose (rate)‏‎ (2 revisions)
  10. Reference biokinetic model‏‎ (2 revisions)
  11. Relocation‏‎ (2 revisions)
  12. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  13. Intervention Level‏‎ (2 revisions)
  14. Substantial radiation dose level‏‎ (2 revisions)
  15. Detriment‏‎ (2 revisions)
  16. Dose-rate effect‏‎ (2 revisions)
  17. Transfer rate‏‎ (2 revisions)
  18. Multi-detector computed tomography‏‎ (2 revisions)
  19. Electron-capture decay‏‎ (2 revisions)
  20. Percutaneous coronary intervention‏‎ (2 revisions)
  21. Prevailing circumstances‏‎ (2 revisions)
  22. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  23. Radon Recommendations for Authorities‏‎ (2 revisions)
  24. Hypoplasia‏‎ (2 revisions)
  25. Backscatter detection system‏‎ (2 revisions)
  26. Reference individual‏‎ (2 revisions)
  27. Bradycardia‏‎ (2 revisions)
  28. Remedial action‏‎ (2 revisions)
  29. Risk of Exposure to Radon‏‎ (2 revisions)
  30. Coronary heart disease‏‎ (2 revisions)
  31. South Atlantic anomaly‏‎ (2 revisions)
  32. Interventional procedure‏‎ (2 revisions)
  33. Decay constant‏‎ (2 revisions)
  34. Lymphatic system‏‎ (2 revisions)
  35. Transforming growth factor‏‎ (2 revisions)
  36. Dose of record Hp (10)‏‎ (2 revisions)
  37. Electrophysiology‏‎ (2 revisions)
  38. Pericarditis‏‎ (2 revisions)
  39. Principle of application of dose limits‏‎ (2 revisions)
  40. Accreditation‏‎ (2 revisions)
  41. Genomic integrity‏‎ (2 revisions)
  42. Radioactivity‏‎ (2 revisions)
  43. Hazard‏‎ (2 revisions)
  44. Radon Recommendations for Workplaces‏‎ (2 revisions)
  45. Reference level‏‎ (2 revisions)
  46. Bragg peak‏‎ (2 revisions)
  47. Remediation‏‎ (2 revisions)
  48. Chronic exposure‏‎ (2 revisions)
  49. Routine monitoring‏‎ (2 revisions)
  50. ICRPædia Guide to Radon‏‎ (2 revisions)
  51. Colony‏‎ (2 revisions)
  52. Cosmic Radiation in Aviation‏‎ (2 revisions)
  53. Special (non-routine) monitoring‏‎ (2 revisions)
  54. Decommissioning‏‎ (2 revisions)
  55. Lifetime risk‏‎ (2 revisions)
  56. Macrophage colony stimulating factor‏‎ (2 revisions)
  57. Dose-threshold‏‎ (2 revisions)
  58. Multiplicative risk projection model‏‎ (2 revisions)
  59. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  60. Action Level‏‎ (2 revisions)
  61. Health Surveillance‏‎ (2 revisions)
  62. Basal cell‏‎ (2 revisions)
  63. Branching fraction‏‎ (2 revisions)
  64. Repopulation‏‎ (2 revisions)
  65. Class SR-0 gases‏‎ (2 revisions)
  66. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  67. Decontamination‏‎ (2 revisions)
  68. Diastasis‏‎ (2 revisions)
  69. Threshold dose for tissue reactions‏‎ (2 revisions)
  70. Magnetosphere‏‎ (2 revisions)
  71. Dose per unit intake coefficient‏‎ (2 revisions)
  72. Emergency‏‎ (2 revisions)
  73. Exposure, external or internal‏‎ (2 revisions)
  74. Graft vs host disease‏‎ (2 revisions)
  75. Air-kerma, incident‏‎ (2 revisions)
  76. Radiographer‏‎ (2 revisions)
  77. Heliosphere‏‎ (2 revisions)
  78. Representative organism (non-human biota)‏‎ (2 revisions)
  79. Class SR-1 gases‏‎ (2 revisions)
  80. Safety‏‎ (2 revisions)
  81. Committed effective dose‏‎ (2 revisions)
  82. Cost-benefit analysis‏‎ (2 revisions)
  83. Specific effective energy‏‎ (2 revisions)
  84. Decontamination factor‏‎ (2 revisions)
  85. Limitation of dose‏‎ (2 revisions)
  86. Transmission detection system‏‎ (2 revisions)
  87. Multistage tumorigenesis‏‎ (2 revisions)
  88. Dose rate‏‎ (2 revisions)
  89. Non-sphericity parameter‏‎ (2 revisions)
  90. Emergency exposure situation‏‎ (2 revisions)
  91. Erythropoietin‏‎ (2 revisions)
  92. Pharynx‏‎ (2 revisions)
  93. Exposure (in the context of inhalation)‏‎ (2 revisions)
  94. Fractionation and dose delivery patterns‏‎ (2 revisions)
  95. Broad beam therapy irradiation technique‏‎ (2 revisions)
  96. Representative person‏‎ (2 revisions)
  97. Class SR-2 gases‏‎ (2 revisions)
  98. Safety case‏‎ (2 revisions)
  99. Committed equivalent dose‏‎ (2 revisions)
  100. Slow repair‏‎ (2 revisions)
  101. Isotropic geometry‏‎ (2 revisions)
  102. Lineal energy‏‎ (2 revisions)
  103. Dichotomous‏‎ (2 revisions)
  104. Thyroid blocking‏‎ (2 revisions)
  105. Transparency‏‎ (2 revisions)
  106. Dose rate effectiveness factor‏‎ (2 revisions)
  107. Waste disposal‏‎ (2 revisions)
  108. Non-targeted effects‏‎ (2 revisions)
  109. Emergency plan‏‎ (2 revisions)
  110. Ethics‏‎ (2 revisions)
  111. ALARA‏‎ (2 revisions)
  112. Procedural values‏‎ (2 revisions)
  113. Hierarchical tissues‏‎ (2 revisions)
  114. Area monitoring‏‎ (2 revisions)
  115. Benthic‏‎ (2 revisions)
  116. Bronchial region‏‎ (2 revisions)
  117. Reproductive integrity‏‎ (2 revisions)
  118. Clearance‏‎ (2 revisions)
  119. Safety culture‏‎ (2 revisions)
  120. Solar cosmic radiation‏‎ (2 revisions)
  121. Inhalability‏‎ (2 revisions)
  122. Spontaneous fission‏‎ (2 revisions)
  123. Itinerant (radiation) worker‏‎ (2 revisions)
  124. Deontological Ethics‏‎ (2 revisions)
  125. Linear-non-threshold model‏‎ (2 revisions)
  126. Differentiation‏‎ (2 revisions)
  127. Trapped particles‏‎ (2 revisions)
  128. Orphan source‏‎ (2 revisions)
  129. Planned exposure situation‏‎ (2 revisions)
  130. Progenitor cell‏‎ (2 revisions)
  131. Activity‏‎ (2 revisions)
  132. Radiation belt‏‎ (2 revisions - redirect page)
  133. High level waste‏‎ (2 revisions)
  134. Reasonableness‏‎ (2 revisions)
  135. Residual dose‏‎ (2 revisions)
  136. Respiratory protection‏‎ (2 revisions)
  137. Clearance level‏‎ (2 revisions)
  138. Scintigraphy‏‎ (2 revisions)
  139. Solar cycle‏‎ (2 revisions)
  140. Inner bremsstrahlung‏‎ (2 revisions)
  141. Systemic model‏‎ (2 revisions)
  142. Linear-quadratic dose response model‏‎ (2 revisions)
  143. Time factor‏‎ (2 revisions)
  144. Dose constraint‏‎ (2 revisions)
  145. Myocardial perfusion‏‎ (2 revisions)
  146. Early normal tissue responses‏‎ (2 revisions)
  147. What is Radon?‏‎ (2 revisions)
  148. Platelet-derived growth factor‏‎ (2 revisions)
  149. Radiation modifier‏‎ (2 revisions)
  150. Radiological protection principles‏‎ (2 revisions)
  151. Beta-minus decay‏‎ (2 revisions)
  152. Retrievability‏‎ (2 revisions)
  153. Immune system‏‎ (2 revisions)
  154. Institutional control‏‎ (2 revisions)
  155. Cumulative dose‏‎ (2 revisions)
  156. Stakeholder‏‎ (2 revisions)
  157. Tachycardia‏‎ (2 revisions)
  158. Tissue equivalent material‏‎ (2 revisions)
  159. Dose conversion coefficient‏‎ (2 revisions)
  160. Myocardial stress test‏‎ (2 revisions)
  161. Edema‏‎ (2 revisions)
  162. Oversight‏‎ (2 revisions)
  163. Excess relative risk‏‎ (2 revisions)
  164. Exposure situation‏‎ (2 revisions)
  165. Projected dose‏‎ (2 revisions)
  166. Growth factor‏‎ (2 revisions)
  167. Alimentary tract transfer factor‏‎ (2 revisions)
  168. Radionuclides of natural origin‏‎ (2 revisions)
  169. Recovery (cellular or tissue)‏‎ (2 revisions)
  170. Beta-plus decay‏‎ (2 revisions)
  171. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  172. Target region‏‎ (3 revisions)
  173. Growth fraction‏‎ (3 revisions)
  174. Excretion rate (instantaneous)‏‎ (3 revisions)
  175. Extrathoracic airways‏‎ (3 revisions)
  176. Galactic cosmic radiation‏‎ (3 revisions)
  177. Growth hormone (somatotropin)‏‎ (3 revisions)
  178. ICRP Publication 103‏‎ (3 revisions)
  179. DNA damage signalling‏‎ (3 revisions)
  180. Potential exposure‏‎ (3 revisions)
  181. Fairness‏‎ (3 revisions)
  182. Absorption‏‎ (3 revisions)
  183. Gamma ray‏‎ (3 revisions)
  184. Cardiomyopathy‏‎ (3 revisions)
  185. Rigidity threshold‏‎ (3 revisions)
  186. Low Earth orbit‏‎ (3 revisions)
  187. Dose equivalent‏‎ (3 revisions)
  188. X ray‏‎ (3 revisions)
  189. Field-size effect (Volume effect)‏‎ (3 revisions)
  190. Gastrointestinal syndrome‏‎ (3 revisions)
  191. Biomedical research volunteer‏‎ (3 revisions)
  192. Dose limit‏‎ (3 revisions)
  193. Unsealed source‏‎ (3 revisions)
  194. Xerostomia‏‎ (3 revisions)
  195. Flexible tissues‏‎ (3 revisions)
  196. Guide to the System of Radiological Protection‏‎ (3 revisions)
  197. Autonomy‏‎ (3 revisions)
  198. Constancy test‏‎ (3 revisions)
  199. Interphase death‏‎ (3 revisions)
  200. Test‏‎ (3 revisions)
  201. Dose‏‎ (3 revisions)
  202. Dose limits‏‎ (3 revisions)
  203. Fluence‏‎ (3 revisions)
  204. Public exposure‏‎ (3 revisions)
  205. DS02‏‎ (3 revisions)
  206. Uptake‏‎ (3 revisions)
  207. Fluoroscopically guided interventions‏‎ (3 revisions)
  208. Annual dose‏‎ (3 revisions)
  209. Cell death‏‎ (3 revisions)
  210. Contamination‏‎ (3 revisions)
  211. Dose of record (E)‏‎ (3 revisions)
  212. Utilitarian ethics‏‎ (3 revisions)
  213. Operational quantity‏‎ (3 revisions)
  214. Accountability‏‎ (3 revisions)
  215. Half-life, physical‏‎ (3 revisions)
  216. Value judgement‏‎ (3 revisions)
  217. Exponential survival curve‏‎ (3 revisions)
  218. Annual limit on intake‏‎ (3 revisions)
  219. Dose per content function‏‎ (3 revisions)
  220. Valvular heart disease‏‎ (3 revisions)
  221. Equity‏‎ (3 revisions)
  222. Personal dose equivalent‏‎ (3 revisions)
  223. Principle of justification‏‎ (3 revisions)
  224. Graded approach‏‎ (3 revisions)
  225. Radiofrequency ablation‏‎ (3 revisions)
  226. Iso-effect plots‏‎ (3 revisions)
  227. Lifetime risk estimates‏‎ (3 revisions)
  228. Virtue ethics‏‎ (3 revisions)
  229. Fractionation‏‎ (3 revisions)
  230. Isomers‏‎ (3 revisions)
  231. Voxel phantom‏‎ (3 revisions)
  232. Active (red) bone marrow‏‎ (3 revisions)
  233. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  234. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  235. Coster-Kronig transition‏‎ (3 revisions)
  236. Organ dose equivalent‏‎ (3 revisions)
  237. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  238. Emergency preparedness‏‎ (3 revisions)
  239. Gray‏‎ (3 revisions)
  240. Spread-out Bragg peak‏‎ (3 revisions)
  241. Emergency procedures‏‎ (3 revisions)
  242. Absolute risk‏‎ (3 revisions)
  243. Auger transition‏‎ (3 revisions)
  244. Recovery‏‎ (3 revisions)
  245. Bystander effect‏‎ (3 revisions)
  246. Complex tissues‏‎ (3 revisions)
  247. Derived air concentration‏‎ (3 revisions)
  248. Dignity‏‎ (3 revisions)
  249. Wisdom‏‎ (3 revisions)
  250. Employer‏‎ (3 revisions)
  251. Activity median thermodynamic diameter‏‎ (3 revisions)
  252. Computed tomography dose index‏‎ (4 revisions)
  253. Direct bioassay‏‎ (4 revisions - redirect page)
  254. Bioassay‏‎ (4 revisions)
  255. Calculating Radon Doses‏‎ (4 revisions)
  256. Alpha decay‏‎ (4 revisions)
  257. Kp index‏‎ (4 revisions)
  258. Effective charge number‏‎ (4 revisions)
  259. Protective action‏‎ (4 revisions)
  260. Reference Animal and Plant‏‎ (4 revisions)
  261. Source-related assessment‏‎ (4 revisions)
  262. Risk‏‎ (4 revisions)
  263. Senescence‏‎ (4 revisions)
  264. Effective half-life‏‎ (4 revisions)
  265. Averted dose‏‎ (4 revisions)
  266. Reference bioassay function‏‎ (4 revisions)
  267. Optimisation‏‎ (4 revisions)
  268. Forbiddenness‏‎ (4 revisions)
  269. Aerodynamic diameter‏‎ (4 revisions)
  270. ICRP‏‎ (4 revisions)
  271. Sievert‏‎ (4 revisions)
  272. Diagnostic reference level‏‎ (4 revisions)
  273. S coefficient (radiation weighted)‏‎ (4 revisions)
  274. Non-maleficence‏‎ (4 revisions)
  275. Air-kerma, product‏‎ (4 revisions)
  276. Fractionation sensitivity‏‎ (4 revisions)
  277. Mass median diameter‏‎ (4 revisions)
  278. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  279. Math‏‎ (4 revisions)
  280. Programmed cell death‏‎ (4 revisions)
  281. High linear energy transfer radiation‏‎ (4 revisions)
  282. Kerma‏‎ (5 revisions)
  283. Protection quantities‏‎ (5 revisions)
  284. Types of materials‏‎ (5 revisions)
  285. Absorbed fraction‏‎ (5 revisions)
  286. Radiation weighting factor‏‎ (5 revisions)
  287. Sources of Radiation Exposure‏‎ (5 revisions)
  288. Quality factor‏‎ (5 revisions)
  289. Air-kerma, entrance surface‏‎ (5 revisions)
  290. Principle of optimisation‏‎ (5 revisions)
  291. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  292. Dose coefficient‏‎ (5 revisions)
  293. Justification‏‎ (5 revisions)
  294. Linear energy transfer‏‎ (6 revisions)
  295. Accelerated fractionation‏‎ (6 revisions)
  296. Investigation level‏‎ (6 revisions)
  297. ICRPædia Guides‏‎ (6 revisions)
  298. Exposure Categories and Situations‏‎ (6 revisions)
  299. Justice‏‎ (6 revisions)
  300. Alimentary tract‏‎ (6 revisions)
  301. Collective effective dose‏‎ (7 revisions)
  302. Prudence‏‎ (8 revisions)
  303. Effects of Exposure‏‎ (8 revisions)
  304. Organ/tissue absorbed dose‏‎ (8 revisions)
  305. Beneficence‏‎ (8 revisions)
  306. Absorbed dose‏‎ (9 revisions)
  307. Objectives of Radiological Protection‏‎ (9 revisions)
  308. Air-kerma rate constant‏‎ (9 revisions)
  309. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  310. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  311. Equivalent dose‏‎ (11 revisions)
  312. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  313. ICRP publications‏‎ (14 revisions)
  314. System of radiation protection module 2‏‎ (14 revisions)
  315. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  316. Tissue weighting factor‏‎ (17 revisions)
  317. Guide to Radon‏‎ (19 revisions)
  318. The System of Radiological Protection‏‎ (21 revisions)
  319. Radon For Homeowners and Residents‏‎ (22 revisions)
  320. Effective dose‏‎ (23 revisions)
  321. Radon For Governments and Employers‏‎ (23 revisions)
  322. Information for healthcare providers (old)‏‎ (24 revisions)
  323. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  324. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  325. Main Page‏‎ (29 revisions)
  326. General Information on Radon‏‎ (31 revisions)
  327. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  328. System Of Radiation Protection Overview‏‎ (43 revisions)
  329. Information for patients, family members, carers and the public‏‎ (62 revisions)
  330. Information for healthcare providers‏‎ (80 revisions)
  331. Application of ionising radiation in healthcare‏‎ (98 revisions)
  332. ICRP Glossary‏‎ (267 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)